News Focus
News Focus
Followers 49
Posts 5519
Boards Moderated 0
Alias Born 07/19/2006

Re: DewDiligence post# 830

Friday, 05/17/2019 4:07:33 PM

Friday, May 17, 2019 4:07:33 PM

Post# of 9090

Efficacy (ASPEN-1)—placebo comparator; 300 patients; single-injection; 36w observation; expected completion Sep 2020



This is a hugely important readout for the company, and it's not that far away. Unlike plantar fasc. which is a high risk trial, this is going to make or break the valuation of the company truly, and everything between now and then is mostly noise (as long as they can get that BLA done by year end)
JMO for all those bitching about the share price